Defining the relationship between COPD and CVD: what are the implications for clinical practice?
Cardiovascular diseases (CVDs) are arguably the most important comorbidities in chronic
obstructive pulmonary disease (COPD). CVDs are common in people with COPD, and their …
obstructive pulmonary disease (COPD). CVDs are common in people with COPD, and their …
Lung function trajectories and chronic obstructive pulmonary disease: current understanding and knowledge gaps
JK Krishnan, FJ Martinez - Current Opinion in Pulmonary Medicine, 2018 - journals.lww.com
A better understanding of lung function development and eventual decline in those at risk for
progression to COPD will aide in a precision medicine approach, in which markers for those …
progression to COPD will aide in a precision medicine approach, in which markers for those …
Characteristics associated with accelerated lung function decline in a primary care population with chronic obstructive pulmonary disease
HR Whittaker, JM Pimenta, D Jarvis… - … journal of chronic …, 2020 - Taylor & Francis
Background Estimates for lung function decline in chronic obstructive pulmonary disease
(COPD) have differed by study setting and have not been described in a UK primary care …
(COPD) have differed by study setting and have not been described in a UK primary care …
Pharmacological therapy of COPD: reasons for optimism
BR Celli - Chest, 2018 - Elsevier
The number of pharmacological medications available to treat patients with COPD has
increased over the past few decades. Most of the improvement has come from the …
increased over the past few decades. Most of the improvement has come from the …
Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review
HR Whittaker, D Jarvis, MR Sheikh, SJ Kiddle… - Respiratory …, 2019 - Springer
Rate of FEV 1 decline in COPD is heterogeneous and the extent to which inhaled
corticosteroids (ICS) influence the rate of decline is unclear. The majority of previous reviews …
corticosteroids (ICS) influence the rate of decline is unclear. The majority of previous reviews …
Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV1 Decline in a COPD Population
Background Electronic healthcare records (EHR) are increasingly used in epidemiological
studies but are often viewed as lacking quality compared to randomised control trials and …
studies but are often viewed as lacking quality compared to randomised control trials and …
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients
Background Patients with myocardial infarction and concomitant COPD are at increased risk
of poor clinical outcomes, including death, as compared to patients without COPD. Aim To …
of poor clinical outcomes, including death, as compared to patients without COPD. Aim To …
Morbidity and mortality associated with chronic obstructive pulmonary disease (COPD)
RC Richie - Journal of Insurance Medicine, 2023 - meridian.allenpress.com
This article summarizes the morbidity and mortality associated with COPD and was created
from a presentation given at the 130th AAIM Annual Meeting. The author reviews what most …
from a presentation given at the 130th AAIM Annual Meeting. The author reviews what most …
Inhalation therapy for repairing damaged elastin fibers and decelerating elastinolysis in chronic obstructive pulmonary disease
R Janssen, I Piscaer, EF Wouters - Expert Review of Respiratory …, 2018 - Taylor & Francis
Introduction: Current pharmacologic therapy of chronic obstructive pulmonary disease
(COPD) can reduce respiratory symptoms and exacerbation frequency. However, no single …
(COPD) can reduce respiratory symptoms and exacerbation frequency. However, no single …